Skip to main content
. Author manuscript; available in PMC: 2009 Oct 2.
Published in final edited form as: J Neuropathol Exp Neurol. 2009 Mar;68(3):250–261. doi: 10.1097/NEN.0b013e318198d320

Figure 5.

Figure 5

1C2 immunoreactivity in diseased control cases. (A)Substantia nigra with aggregated cytoplasmic immunoreactivity in neurons and adjacent macrophages. (B) Neurons of locus coeruleus with cytoplasmic immunoreactivity. (C) Neurohypophysis with cytoplasmic immunoreactivity.